These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

433 related items for PubMed ID: 15116055

  • 41. Multidrug resistance 1 genotype and disposition of budesonide in early primary biliary cirrhosis.
    Dilger K, Cascorbi I, Grünhage F, Hohenester S, Sauerbruch T, Beuers U.
    Liver Int; 2006 Apr; 26(3):285-90. PubMed ID: 16584389
    [Abstract] [Full Text] [Related]

  • 42. Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part II.
    Staatz CE, Goodman LK, Tett SE.
    Clin Pharmacokinet; 2010 Apr; 49(4):207-21. PubMed ID: 20214406
    [Abstract] [Full Text] [Related]

  • 43. Tacrolimus dose requirement in relation to donor and recipient ABCB1 and CYP3A5 gene polymorphisms in Chinese liver transplant patients.
    Wei-lin W, Jing J, Shu-sen Z, Li-hua W, Ting-bo L, Song-feng Y, Sheng Y.
    Liver Transpl; 2006 May; 12(5):775-80. PubMed ID: 16628701
    [Abstract] [Full Text] [Related]

  • 44. Modulation of steady-state kinetics of digoxin by haplotypes of the P-glycoprotein MDR1 gene.
    Johne A, Köpke K, Gerloff T, Mai I, Rietbrock S, Meisel C, Hoffmeyer S, Kerb R, Fromm MF, Brinkmann U, Eichelbaum M, Brockmöller J, Cascorbi I, Roots I.
    Clin Pharmacol Ther; 2002 Nov; 72(5):584-94. PubMed ID: 12426522
    [Abstract] [Full Text] [Related]

  • 45. Associations between common variants in the MDR1 (ABCB1) gene and ulcerative colitis among North Indians.
    Juyal G, Midha V, Amre D, Sood A, Seidman E, Thelma BK.
    Pharmacogenet Genomics; 2009 Jan; 19(1):77-85. PubMed ID: 19005421
    [Abstract] [Full Text] [Related]

  • 46. The effects of the human MDR1 genotype on the expression of duodenal P-glycoprotein and disposition of the probe drug talinolol.
    Siegmund W, Ludwig K, Giessmann T, Dazert P, Schroeder E, Sperker B, Warzok R, Kroemer HK, Cascorbi I.
    Clin Pharmacol Ther; 2002 Nov; 72(5):572-83. PubMed ID: 12426521
    [Abstract] [Full Text] [Related]

  • 47. Influence of functional polymorphisms of the MDR1 gene on vincristine pharmacokinetics in childhood acute lymphoblastic leukemia.
    Plasschaert SL, Groninger E, Boezen M, Kema I, de Vries EG, Uges D, Veerman AJ, Kamps WA, Vellenga E, de Graaf SS, de Bont ES.
    Clin Pharmacol Ther; 2004 Sep; 76(3):220-9. PubMed ID: 15371983
    [Abstract] [Full Text] [Related]

  • 48. Tacrolimus dosing in Chinese renal transplant patients is related to MDR1 gene C3435T polymorphisms.
    Li D, Gui R, Li J, Huang Z, Nie X.
    Transplant Proc; 2006 Nov; 38(9):2850-2. PubMed ID: 17112846
    [Abstract] [Full Text] [Related]

  • 49. The effect of MDR1 (ABCB1) polymorphism on the pharmacokinetic of tacrolimus in Turkish renal transplant recipients.
    Akbas SH, Bilgen T, Keser I, Tuncer M, Yucetin L, Tosun O, Gultekin M, Luleci G.
    Transplant Proc; 2006 Jun; 38(5):1290-2. PubMed ID: 16797284
    [Abstract] [Full Text] [Related]

  • 50. Population pharmacokinetics of cyclosporine in kidney and heart transplant recipients and the influence of ethnicity and genetic polymorphisms in the MDR-1, CYP3A4, and CYP3A5 genes.
    Hesselink DA, van Gelder T, van Schaik RH, Balk AH, van der Heiden IP, van Dam T, van der Werf M, Weimar W, Mathot RA.
    Clin Pharmacol Ther; 2004 Dec; 76(6):545-56. PubMed ID: 15592326
    [Abstract] [Full Text] [Related]

  • 51. Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part I.
    Staatz CE, Goodman LK, Tett SE.
    Clin Pharmacokinet; 2010 Mar; 49(3):141-75. PubMed ID: 20170205
    [Abstract] [Full Text] [Related]

  • 52. Do drug transporter (ABCB1) SNPs influence cyclosporine and tacrolimus dose requirements and renal allograft outcome in the posttransplantation period?
    Singh R, Srivastava A, Kapoor R, Mittal RD.
    J Clin Pharmacol; 2011 Apr; 51(4):603-15. PubMed ID: 20571034
    [Abstract] [Full Text] [Related]

  • 53. Influence of ABCB1, CYP3A4*18B and CYP3A5*3 polymorphisms on cyclosporine A pharmacokinetics in bone marrow transplant recipients.
    Qiu F, He XJ, Sun YX, Li-Ling J, Zhao LM.
    Pharmacol Rep; 2011 Apr; 63(3):815-25. PubMed ID: 21857093
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. The effects of relative timing of sirolimus and cyclosporine microemulsion formulation coadministration on the pharmacokinetics of each agent.
    Kaplan B, Meier-Kriesche HU, Napoli KL, Kahan BD.
    Clin Pharmacol Ther; 1998 Jan; 63(1):48-53. PubMed ID: 9465841
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Haplotype-based analysis of MDR1/ABCB1 gene polymorphisms in a Turkish population.
    Gümüş-Akay G, Rüstemoğlu A, Karadağ A, Sunguroğlu A.
    DNA Cell Biol; 2010 Feb; 29(2):83-90. PubMed ID: 20025534
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.